FCF Grants Awarded in 2016
Total grants: 10
- Cancer Research Institute (CRI) fellowship program — Cancer Research Institute
- Developing therapeutics for fibrolamellar hepatocellular carcinoma — Principal investigator(s): Sandy Simon — Rockefeller University
- Flipping the switch on PKA: synthetic lethal approaches to block PKA-driven tumor growth in fibrolamellar liver cancer — Principal investigator(s): John Gordan, Nabeel Bardeesy — University of California at San Francisco, Massachusetts General Hospital
- Characterizing enzyme inhibition of the DnaJPKAc chimeric protein derived from fibrolamellar hepatocellular carcinomas — Principal investigator(s): Hibba tul Rehman — University of Vermont
- Kinase fusion function investigation — Principal investigator(s): Yi Guo — Mayo Clinic
- Pre-clinical studies of the interactions of the immune system with FL-HCC — Principal investigator(s): Kevin Barry — University of California at San Francisco
- Investigating immune checkpoint biomarkers in tissue and peripheral blood of patients with fibrolamellar hepatocellular carcinoma — Principal investigator(s): Amy K. Kim — Johns Hopkins University
- T cell immunotherapy in fibrolamellar cancer — Principal investigator(s): Kevin M. Sullivan — University of Washington
- Developing pre-clinical models for fibrolamellar FL-HCC: therapeutic target identification and testing — Principal investigator(s): Julien Sage — Stanford University
- Role of the innate immune system in fibrolamellar hepatocellular carcinoma (FL-HCC) using zebrafish as a model system — Principal investigator(s): Sofia de Oliveira — University of Wisconsin
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded in 2016. The name of the grant is listed, along with the institution receiving the grant and the principal investigator.